Article

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice

2024-09-24

Abstract excerpt

Liver disease, including hepatocellular carcinoma (HCC), is a major global health concern, claiming approximately 2 million lives worldwide annually, yet curative treatments remain elusive. In this study, we aimed to investigate the role of microRNA-21-5p (miR-21) in metabolic dysfunction-associated steatotic liver disease (previously NAFLD), metabolic-associated steatohepatitis (previously NASH), and HCC within t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b7875ff7-8c06-5fd7-b39d-4976e96908e2
DOI: 10.1101/2024.09.19.613915

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed miceDOI 10.1101/2024.09.19.613915Read

microRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinomaSemantic proximity Read

Critical Role of microRNA-21 in the Pathogenesis of Liver DiseasesSemantic proximity Read

miR-21 blocks obesity in mice: a potential therapy for humansSemantic proximity Read

Mammalian Ste20-Like Kinase 1 Regulates AMPK to Mitigate the Progression of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.Semantic proximity Read

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

miRNAs and NAFLD: from pathophysiology to therapySemantic proximity Read

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesisSemantic proximity Read

Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessmentSemantic proximity Read

Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1Semantic proximity Read

Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity Read

MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunitiesSemantic proximity Read